You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03)
|
|---|---|
| Published in |
Journal of Clinical Oncology, December 2021
|
| DOI | 10.1200/jco.21.02554 |
| Pubmed ID | |
| Authors |
Michael Gnant, Amylou C. Dueck, Sophie Frantal, Miguel Martin, Hal J. Burstein, Richard Greil, Peter Fox, Antonio C. Wolff, Arlene Chan, Eric P. Winer, Georg Pfeiler, Kathy D. Miller, Marco Colleoni, Jennifer M. Suga, Gabor Rubovsky, Judith M. Bliss, Ingrid A. Mayer, Christian F. Singer, Zbigniew Nowecki, Olwen Hahn, Jacqui Thomson, Norman Wolmark, Kepa Amillano, Hope S. Rugo, Guenther G. Steger, Blanca Hernando Fernández de Aránguiz, Tufia C. Haddad, Antonia Perelló, Meritxell Bellet, Hannes Fohler, Otto Metzger Filho, Anita Jallitsch-Halper, Kadine Solomon, Céline Schurmans, Kathy P. Theall, Dongrui R. Lu, Kathleen Tenner, Christian Fesl, Angela DeMichele, Erica L. Mayer, on behalf of the PALLAS groups and investigators |
X Demographics
The data shown below were collected from the profiles of 46 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 10 | 22% |
| Spain | 8 | 17% |
| Austria | 2 | 4% |
| Italy | 1 | 2% |
| United Kingdom | 1 | 2% |
| Canada | 1 | 2% |
| Colombia | 1 | 2% |
| Argentina | 1 | 2% |
| Ecuador | 1 | 2% |
| Other | 3 | 7% |
| Unknown | 17 | 37% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 30 | 65% |
| Practitioners (doctors, other healthcare professionals) | 8 | 17% |
| Scientists | 7 | 15% |
| Science communicators (journalists, bloggers, editors) | 1 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 84 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 84 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 10 | 12% |
| Researcher | 10 | 12% |
| Student > Doctoral Student | 9 | 11% |
| Student > Ph. D. Student | 7 | 8% |
| Student > Master | 4 | 5% |
| Other | 5 | 6% |
| Unknown | 39 | 46% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 33 | 39% |
| Biochemistry, Genetics and Molecular Biology | 3 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 2% |
| Agricultural and Biological Sciences | 2 | 2% |
| Neuroscience | 2 | 2% |
| Other | 2 | 2% |
| Unknown | 40 | 48% |
Attention Score in Context
This research output has an Altmetric Attention Score of 365. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 February 2024.
All research outputs
#87,003
of 25,392,582 outputs
Outputs from Journal of Clinical Oncology
#171
of 22,059 outputs
Outputs of similar age
#2,576
of 513,747 outputs
Outputs of similar age from Journal of Clinical Oncology
#5
of 134 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,059 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.0. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 513,747 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 134 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.